What Type of Clinical Research Happens at Cincinnati Eye Institute?
Our doctors are always seeking solutions for eye conditions and vision issues and our research spans across a range of specialties. Clinical studies at Cincinnati Eye Institute all follow stringent national and international standards and are undertaken under the auspices of independent (unaffiliated) Institutional Review Boards. Examples of research topics include:
New and Innovative Ocular Medications
- Dry Eye Medications and New Treatment Approaches
- Ocular Surface Disease
- Glaucoma Medications
- Dry Macular Degeneration
- Wet Macular Degeneration
- Diabetic Retinopathy
- Diabetic Macular Edema
Novel Surgical Procedures, Devices, and Intraocular Implants
- Intraocular Lenses for Cataract Surgery
- Micro-Invasive Glaucoma Devices
- Specialized Corneal Transplantation
- Artificial Iris Devices
- Diabetic Macular Edema
- Wet Macular Degeneration
Revolutionary Research on Common and Rare Eye Disease
- Gene Therapy – Retinitis Pigmentosa, Achromatopsia, Choroideremia, Dry Macular Degeneration, Wet Macular Degeneration
Why Choose Cincinnati Eye Institute For Clinical Research?
Our Clinical Research Facilities
- State-of-the-art imaging and diagnostic equipment
- Dedicated, visual acuity testing rooms
- Designated monitoring rooms with high speed internet and phone access
- On-site pharmacy with BioSafety Cabinet and -80C Freezer
Our Clinical Research Staff
- Experienced and award-winning eye doctors
- Dedicated clinical research coordinators
- CPR and ACLS certified RNs
- Certified Ophthalmic Technicians and Photographers
- Trained personnel for handling/preparing for transportation of dangerous goods
Our Clinical Research Process
- Adherence to Good Clinical Practice guidelines
- Customized standard operating procedures
- Excellent subject retention
- Direct oversight by PI and Research Directors
Notable Clinical Research at CEI
We have a track record of successful clinical studies that include a broad range of ophthalmological specialties and modalities. We have over 18 investigators that have participated in over 240 clinical trials and have treated more than 1,500 patients over the past ten years.